BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7637150)

  • 1. Continuous ambulatory esophageal pH monitoring in the evaluation of patients with gastroesophageal reflux. Diagnostic and Therapeutic Technology Assessment.
    JAMA; 1995 Aug 23-30; 274(8):662-8. PubMed ID: 7637150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic technology assessment. Transjugular intrahepatic portosystemic shunt (TIPS).
    Miller-Catchpole R
    JAMA; 1995 Jun; 273(23):1824-30. PubMed ID: 7776491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic herniorrhaphy. Diagnostic and therapeutic technology assessment.
    JAMA; 1996 Apr; 275(14):1075-82. PubMed ID: 8601916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain.
    Lemire S
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():37B-40B. PubMed ID: 9347176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease.
    Mattox HE; Richter JE
    Am J Med; 1990 Sep; 89(3):345-56. PubMed ID: 2203264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA; Paoletti V; Leite L; Castell DO
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [24-hour esophageal pH monitoring in adults. Apropos of a series of 116 patients].
    Honein K; Slim R; Abdel Malak N; Bou-Jaoude J; Sayegh R; Nasr W; Khouri K
    J Med Liban; 1998; 46(4):189-93. PubMed ID: 9880984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical?
    Armstrong D; Emde C; Inauen W; Blum AL
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():3-13. PubMed ID: 1577393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group.
    Richter JE; Pandolfino JE; Vela MF; Kahrilas PJ; Lacy BE; Ganz R; Dengler W; Oelschlager BK; Peters J; DeVault KR; Fass R; Gyawali CP; Conklin J; DeMeester T;
    Dis Esophagus; 2013; 26(8):755-65. PubMed ID: 22882487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring.
    Kadakia SC; Kikendall JW; Maydonovitch C; Johnson LF
    Am J Gastroenterol; 1995 Oct; 90(10):1785-90. PubMed ID: 7572895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?
    Vardar R; Keskin M
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S16-S21. PubMed ID: 29199161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.
    Patel DA; Sharda R; Choksi YA; Slaughter JC; Higginbotham T; Garrett CG; Francis DO; Ravi K; Hasak S; Katzka D; Gyawali CP; Vaezi MF
    Gastroenterology; 2018 Dec; 155(6):1729-1740.e1. PubMed ID: 30170117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications, technique, and clinical use of ambulatory 24-hour esophageal motility monitoring in a surgical practice.
    Stein HJ; DeMeester TR
    Ann Surg; 1993 Feb; 217(2):128-37. PubMed ID: 8439211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertensive lower esophageal sphincter pressures and gastroesophageal reflux: an apparent paradox that is not unusual.
    Katzka DA; Sidhu M; Castell DO
    Am J Gastroenterol; 1995 Feb; 90(2):280-4. PubMed ID: 7847301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
    Issing WJ; Tauber S; Folwaczny C; Reichel O
    Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [24-hour esophageal impedance-ph monitoring: technical aspects, indications and results].
    Karoui S; Ben Temime H; Serghini M; Zouiten L; Boubaker J; Filali A
    Tunis Med; 2012 May; 90(5):351-6. PubMed ID: 22585640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous noncardiac chest pain. Evaluation by 24-hour ambulatory esophageal motility and pH monitoring.
    Peters L; Maas L; Petty D; Dalton C; Penner D; Wu W; Castell D; Richter J
    Gastroenterology; 1988 Apr; 94(4):878-86. PubMed ID: 3345887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.